Literature DB >> 26520623

Impact of telomere length on survival in classic and variant hairy cell leukemia.

Evgeny Arons1, Hong Zhou1, Daniel C Edelman2, Allison Gomez2, Seth M Steinberg3, David Petersen2, Yonghong Wang2, Paul S Meltzer2, Robert J Kreitman4.   

Abstract

Telomeres, which protect the ends of chromosomes, are shortened in several hematologic malignancies, often with adverse prognostic implications, but their effect on prognosis of classic and variant hairy cell leukemia (HCL and HCLv) has not been reported. HCL/HCLv genomic DNA from 46 patients was studied by PCR to determine the ratio of telomere to single copy gene number (T/S). T/S was unrelated to diagnosis of HCL or HCLv (p=0.27), but shorter T/S was associated with unmutated immunoglobulin rearrangements (p=0.033) and age above the median at diagnosis (p=0.017). Low T/S was associated with shorter overall survival from diagnosis (OS), particularly T/S <0.655 (p=0.0064, adjusted p=0.019). Shorter OS was also associated with presence of unmutated (p<0.0001) or IGHV4-34+ (p<0.0001) rearrangements, or increasing age (p=0.0002). Multivariable analysis with Cox modeling showed that short T/S along with either unmutated or IGHV4-34+ rearrangements remained associated with reduced OS (p=0.0071, p=0.0024, respectively) after age adjustment. While T/S is relatively long in HCL and the disease usually indolent with excellent survival, shortened telomeres in HCL/HCLv are associated with decreased survival. Shortened T/S could represent a risk factor needing further investigation/intervention to determine if non-chemotherapy treatment options, in addition to or instead of chemotherapy, might be particularly useful. Published by Elsevier Ltd.

Entities:  

Keywords:  Chromosomes; DNA damage; Hairy cell leukemia; Molecular marker; Telomere

Mesh:

Substances:

Year:  2015        PMID: 26520623      PMCID: PMC4661072          DOI: 10.1016/j.leukres.2015.09.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  44 in total

Review 1.  Immunoconjugates and new molecular targets in hairy cell leukemia.

Authors:  Robert J Kreitman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

2.  Telomere length in mantle cell lymphoma.

Authors:  Billy Michael Chelliah Jebaraj; Dirk Kienle; André Lechel; Daniel Mertens; Maria Heuberger; German Ott; Andreas Rosenwald; Thomas F E Barth; Peter Möller; Thorsten Zenz; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

3.  Telomeres and chromosomal instability in chronic lymphocytic leukemia.

Authors:  L Véronèse; O Tournilhac; M Callanan; N Prie; F Kwiatkowski; P Combes; M Chauvet; F Davi; L Gouas; P Verrelle; R Guièze; P Vago; J O Bay; A Tchirkov
Journal:  Leukemia       Date:  2012-07-13       Impact factor: 11.528

Review 4.  Telomere dysfunction and its role in haematological cancer.

Authors:  Ceri H Jones; Chris Pepper; Duncan M Baird
Journal:  Br J Haematol       Date:  2012-01-11       Impact factor: 6.998

5.  Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.

Authors:  Enrico Tiacci; Gianluca Schiavoni; Francesco Forconi; Alessia Santi; Livio Trentin; Achille Ambrosetti; Debora Cecchini; Elisa Sozzi; Paola Francia di Celle; Cristiana Di Bello; Alessandro Pulsoni; Robin Foà; Giorgio Inghirami; Brunangelo Falini
Journal:  Blood       Date:  2011-10-25       Impact factor: 22.113

6.  Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.

Authors:  A M Aalbers; R T Calado; N S Young; C M Zwaan; C Wu; S Kajigaya; E A Coenen; A Baruchel; K Geleijns; V de Haas; G J L Kaspers; T W Kuijpers; D Reinhardt; J Trka; M Zimmermann; R Pieters; V H J van der Velden; M M van den Heuvel-Eibrink
Journal:  Leukemia       Date:  2013-02-21       Impact factor: 11.528

7.  Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.

Authors:  Thet Thet Lin; Kevin Norris; Nicole H Heppel; Guy Pratt; James M Allan; David J Allsup; James Bailey; Lynn Cawkwell; Robert Hills; Julia W Grimstead; Rhiannon E Jones; Bethan Britt-Compton; Chris Fegan; Duncan M Baird; Chris Pepper
Journal:  Br J Haematol       Date:  2014-07-03       Impact factor: 6.998

8.  Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study.

Authors:  Yong Cui; Qiuyin Cai; Shimian Qu; Wong-Ho Chow; Wanqing Wen; Yong-Bing Xiang; Jie Wu; Nathaniel Rothman; Gong Yang; Xiao-Ou Shu; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

9.  Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.

Authors:  Robert J Kreitman; Wyndham Wilson; Katherine R Calvo; Evgeny Arons; Laura Roth; Jeffrey Sapolsky; Hong Zhou; Mark Raffeld; Maryalice Stetler-Stevenson
Journal:  Clin Cancer Res       Date:  2013-11-25       Impact factor: 12.531

10.  High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.

Authors:  Joshua J Waterfall; Evgeny Arons; Robert L Walker; Marbin Pineda; Laura Roth; J Keith Killian; Ogan D Abaan; Sean R Davis; Robert J Kreitman; Paul S Meltzer
Journal:  Nat Genet       Date:  2013-11-17       Impact factor: 38.330

View more
  6 in total

1.  Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.

Authors:  Xiaoning Luo; Erich M Sturgis; Zheng Yang; Yan Sun; Peng Wei; Zhensheng Liu; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2019-07-06       Impact factor: 4.944

Review 2.  Telomere Length and Hematological Disorders: A Review.

Authors:  Beatriz Maria Dias Nogueira; Caio Bezerra Machado; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

3.  Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.

Authors:  Baiyu Yang; Fatma M Shebl; Lawrence R Sternberg; Andrew C Warner; David E Kleiner; Daniel C Edelman; Allison Gomez; Casey L Dagnall; Belynda D Hicks; Sean F Altekruse; Brenda Y Hernandez; Charles F Lynch; Paul S Meltzer; Katherine A McGlynn
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

4.  Association of Leukocyte Telomere Length With Mortality Among Adult Participants in 3 Longitudinal Studies.

Authors:  Konstantin G Arbeev; Simon Verhulst; Troels Steenstrup; Jeremy D Kark; Olivia Bagley; Charles Kooperberg; Alexander P Reiner; Shih-Jen Hwang; Daniel Levy; Annette L Fitzpatrick; Kaare Christensen; Anatoliy I Yashin; Abraham Aviv
Journal:  JAMA Netw Open       Date:  2020-02-05

5.  Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Authors:  Rudolf Benz; Kornelius Arn; Martin Andres; Thomas Pabst; Michael Baumann; Urban Novak; Felicitas Hitz; Urs Hess; Reinhard Zenhaeusern; Yves Chalandon; Ulrich Mey; Sabine Blum; Daniel Rauch; Alix O'Meara Stern; Nathan Cantoni; Mario Bargetzi; Elena Bianchi-Papina; Davide Rossi; Jakob Passweg; Andreas Lohri; Simona Berardi; Qiyu Li; Anita Feller; Georg Stussi
Journal:  Blood Adv       Date:  2020-08-11

Review 6.  Revisiting Telomere Shortening in Cancer.

Authors:  Keiji Okamoto; Hiroyuki Seimiya
Journal:  Cells       Date:  2019-01-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.